| Financial Year |
March 31 2023 |
| Monetary Funds |
9,985,610,319.21 |
| Held-for-trading Financial Assets |
54,932,245.21 |
| Notes Receivable |
681,051.59 |
| Accounts Receivable |
6,584,757,415.37 |
| Advances to Suppliers |
64,538,030.81 |
| Other Receivables |
369,086,638.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,262,312,152.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
390,359,639.08 |
| Total Current Assets |
23,717,595,079.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
462,713,796.27 |
| Investment Properties |
941,533,024.66 |
| Fixed Assetes |
35,266,794,182.24 |
| Under-construction Projects |
1,248,994,944.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,147,918,001.80 |
| R&D expenses |
-- |
| Goodwill |
2,970,144,229.35 |
| Long-Term Deferred and Prepaid Expenses |
278,860,586.47 |
| Deferred Income Tax Assets |
1,340,746,452.88 |
| Other Non-Current Assets |
721,066,614.20 |
| Sub-Total of Non-Current Assets |
49,218,117,796.63 |
| Total Assets |
72,935,712,876.26 |
| Short-Term Loans |
2,251,849,178.80 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
8,708,873,405.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,253,546,338.62 |
| Taxes Payable |
196,954,006.50 |
| Interest Payable |
-- |
| Dividend Payable |
37,455,857.20 |
| Other payables |
387,247,430.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,010,861,096.47 |
| Other Current Liabilities |
46,319,786.84 |
| Sub-Total of Current Liabilities |
15,864,650,979.54 |
| Long-term Loans |
9,988,720,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,036,881,944.43 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,310,091.19 |
| Deferred Income Tax Liabilities |
745,799,187.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,663,698,268.59 |
| Total Liabilities |
28,528,349,248.13 |
| Paid-In Capital(Or Share Stock) |
4,973,479,998.00 |
| Capital Surplus |
20,700,138,966.96 |
| Surplus Reserve |
2,189,525,553.28 |
| LESS:Treasury Stock |
500,057,217.81 |
| Undistributed Profits |
16,575,325,438.57 |
| Minority Stockholder's Interest |
173,677,543.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
44,233,686,084.14 |
| Owner's Equity（Stockholder's Equity） |
44,407,363,628.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
72,935,712,876.26 |
